Regeneron Pharmaceuticals Inc (NASDAQ: REGN)
Regeneron Pharmaceuticals stock is having a great day in the market today after releasing its results from the second quarter. Today, we’ll take a look at REGN’s Q2 results, how investors reacted to the news, and what we can expect to see moving forward. So, let’s get right to it…
REGN Tops Q2 Estimates In A Big Way
As mentioned above, Regeneron Pharmaceuticals released their earnings report for the second quarter; and the report was a hit. Here are the details that we saw…
- Earnings Per Share – In the second quarter, analysts were expecting that Regeneron Pharmaceuticals would report earnings of $1.81. However, the company actually produced earnings in the amount of $2.12 per share; $0.31 ahead of analyst expectations.
- Top-Line Revenue – Regeneron also produced incredibly strong top-line revenue figures. In the second quarter, REGN produced $998.6 million; coming to $107.6 million ahead of analyst expectations of $891 million.
- Eylea Sales – The key focus on the earnings report proved to be Eylea sales. The company produced incredibly strong sales in that respect. As a result, they have increased revenue guidance from between a 30% and 35% growth to between 45% and 50% growth over last year.
As you can see from the data above, the earnings report produced by Regeneron Pharmaceuticals proved to be incredibly positive.
How The Market Reacted To The News
As we’ve come to expect any time we see positive news in an earnings report, Regeneron Pharmaceuticals is having a great day in the market today as a result. Currently (12:48), REGN is trading at $587.08 per share after a gain of 5.92% so far today.
What We Can Expect To See Moving Forward
Moving forward, I’m expecting to see more positive news out of Regeneron Pharmaceuticals. Through their earnings report, they have proved that Eylea is more successful than anyone expected it to be; which will lead to gains in the long run. Also, considering that the company has a strong history of producing better-than-expected earnings, a strong team, and a great plan for growth; I’m expecting more good news in the days, weeks, months and years ahead.
What Do You Think?
Where do you think REGN is headed and why? Let us know in the comments below!